Xilio Therapeutics (XLO) EBT Growth (1y) (2021 - 2026)
Xilio Therapeutics (XLO) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Xilio Therapeutics | 144.35 Mn | -5.95 Mn | - | -1.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.59% |
| Dec 31, 2025 | 14.72% |
| Sep 30, 2025 | 86.56% |
| Jun 30, 2025 | 3.19% |
| Mar 31, 2025 | 21.86% |
| Dec 31, 2024 | 27.60% |
| Sep 30, 2024 | 14.61% |
| Jun 30, 2024 | 26.32% |
| Mar 31, 2024 | 25.00% |
| Dec 31, 2023 | 21.33% |
| Sep 30, 2023 | 14.79% |
| Jun 30, 2023 | 18.66% |
| Mar 31, 2023 | -10.79% |
| Dec 31, 2022 | -24.24% |
| Sep 30, 2022 | 35.68% |
| Jun 30, 2022 | -7.43% |
| Mar 31, 2022 | -28.13% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | -114.29% |